The immunological activity apparent in rheumatoid arthritis (RA) has led to speculation that an altered state of immune reactivity may play a role in the development of this disease. It has also led to the clinical testing of drugs such as azathioprine thought to reduce immune responsiveness. However, numerous studies of immune reactivity in RA have produced conflicting results, with no consistent evidence of altered antibody production or specific cellular immunity. Rheumatoid patients have also generally not shown any consistent alteration in the numbers or ratios of circulating immunocyte subpopulations. In addition, effective treatment of RA by 'immunosuppressive' drugs is usually not associated with any obvious reduction in immune responsiveness, thus making it difficult to monitor this type of treatment (Currey, 1978) .
Two in-vitro reactions provideconvenient measurements of the ability of separate subgroups of peripheral blood leucocytes to lyse target cells (Podleski, 1976) . The one is antibody-dependent cell mediated cytotoxicity (ADCC), in which a subpopulation of lymphocytes (killer, or K cells) produces lysis of cells to which antibody is specifically bound (Perlmann and Perlmann, 1970) ; the other is phytohaemagglutinin (PHA)-induced cytotoxicity (Perlmann and Holm, 1969) . Our interest in these 2 reactions arose from the observations of Campbell et al. (1976) For this reason we have used these 2 tests to seek differences between rheumatoid subjects and others, and, among patients with RA, differences between those receiving and those not receiving 'slow acting' drugs such as azathioprine.
Patients
Seventy-seven patients with classical or definite RA as defined by the American Rheumatism Association (Ropes, 1959) and 17 healthy persons were tested for ADCC. Treatment groups and clinical and laboratory details are shown in Table 1 . The erythrocyte sedimentation rate (ESR) (Westergren) was used as a measure of disease activity. Drug dosage and duration of treatment were recorder foi each patient. Among those taking azathioprine the mean cumulative dose was 75 g (range 3 to 272 g), and the mean duration of therapy was 23 * 5 months (range 1 to 84 months.
Twenty-two patients with RA and 10 healthy persons were also investigated for PHA-induced cytotoxicity.
Methods EFFECTOR CELLS
Lymphocytes were obtained from heparinised venous The median value for each triplicate determination was used.
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PHA-INDUCED CYTOTOXICITY 50 ,ud PHA (Wellcome Reagents Ltd.) was substituted for antiserum in the system described above. The concentrations of PHA used were 3 x 10-4, 3 x 10-5, and 3 x 10-6 mg/mI.
Results

ANTIBODY-DEPENDENT CELL MEDIATED CYTOTOXICITY
One hundred and thirty-nine determinations of ADCC were made on the subjects described ( (Table 4) . Froland et al. (1975) , and Feldmann et al. (1976) . These authors used a similar CRBC system. Panayi and Corrigall (1977) obtained comparable results using a Chang cell system. There are, however, reports of both increased (Sany et al., 1976) and decreased ADCC in RA (Isturiz et al., 1976; McGill and Twinn, 1977) . It has been suggested that a reduction in ADCC might be due to a blocking effect of immune complexes in these patients. Discrepant results could also reflect differences in technique. These include the method of lymphocyte separation (Mookerjee, 1976) , varying effector target cell ratios, and incubation periods. McGill and Twinn (1977) correlated ADCC with seropositivity and disease activity. However, 14 of their 39 seropositive patients had a CT of 10% or less, of whom 7 had no demonstrable cytotoxicity. Only 1 of our patients had a CI of less than 10%, and we were unable to find any correlation between cytotoxicity and disease activity or seropositivity.
Drug treatment, in particular azathioprine, did not appear to influence ADCC in our RA patients. The fall in ADCC following azathioprine therapy reported by Campbell et al. (1976) occurred in patients receiving the drug for ulcerative colitis, not RA. Furthermore, these authors employed a Chang cell system and calculated CI in a manner which makes comparisons with our own and other studies difficult.
Our results do not confirm the reduction in PHAinduced cytotoxicity in RA reported by Wisloff et al. (1975) . Differences in the method of separating lymphocytes might possibly explain this discrepancy, for mitogenic responses of lymphocytes in RA vary with the subpopulation examined (Silverman et al., 1976; Rawson and Huang, 1976 ).
In conclusion, our studies of cellular cytotoxicity have not revealed any alterations attributable to RA or drugs, including azathioprine. 
